Navigation Links
Prostate Cancer Risk Linked To Early Estrogen Exposure

estrogen or BPA exposure permanently changed the methylation, or tagging, of specific stretches of DNA in the neonate's prostate cells, a phenomenon referred to as epigenetic reprogramming. In epigenetic reprogramming, gene expression is altered without changing DNA sequences or content. Several of the epigenetically altered sites turned out to be in important genes that regulate cellular functions.

The researchers conclude that exposure to environmental estrogens, such as BPA, or natural estrogens affect the pattern of gene expression in the prostate during development, and in so doing promote prostate disease with aging.

One of the altered genes, phosphodiesterase 4 (PDE4D4), was examined in greater detail. The researchers found that the methylation of PDE4D4 can permanently change its pattern of expression in the prostate. This gene should normally shut down in adult life, but after early exposure to estradiol or BPA, the exposed animals' prostates continued to express it at high levels. Similar high levels due to methylation of the gene were found in prostate cancer cells but not in normal cell lines.

Because the methylation marks of epigenetic reprogramming were found before any disease was observed, the methylation may be useful as a way to identify men at higher prostate disease risk, Prins said, which may have resulted from early exposure to endocrine disruptors.

These findings are true for an animal model, and application to human prostate disease will await future studies, the authors concluded. Ho is first author of the study and professor and chairman of environmental health at the University of Cincinnati.

(Source: Newswise)
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread

Post Your Comments:
(Date:11/23/2009)...WHAT: ,, TheBerylInstitute, theresearchandedu...ghealthcareexclusivecallcenter,issponsoringafreeWe...tionwithapositivecustomerserviceexperience.Hostedb...llsupplementHowe,sJune2009whitepaper,"CustomerExpe...consumerswillultimatelytransformhealthcaredelivery...
(Date:11/23/2009)...-InasurveyofNewJerseyandPhiladelphiaregionalChiefE...tdonotbelieveanewhealthcarebillwouldlikelyresultin...fthelatestsurveyconductedbytheAlloySilversteinGrou...listat85percentasthebiggestnationalissue.Thissurve...niesfromallpartsofNewJerseyandSoutheasternPennsylv...
(Date:11/23/2009)...self-reported by American surgeons are strongly re...gs appear today in the online edition of Annals o...laborators from Johns Hopkins and the American Col..., nearly 9 percent of U.S. surgeons responding sai...r to being surveyed. Over 70 percent attributed th...
(Date:11/23/2009)...r more screen time than those in center-based care...hDay News) --Young children of working parents may...s reports have found, especially kids in home-base...rchers from Seattle Children,s Hospital and the Un... to find out how much television viewing was avail...
(Date:11/23/2009)...UnitedConcordiaDental,oneofthenation,slargestdenta...ww.unitedconcordia.comwhichprovidesimprovedaccesst...sts. ,, "Thesiteboastsacleandesign,betterorgani...visitorsfindinformationquicklyandeasily,"saidPaulJ...tor."Fresh,relevantcontent,coupledwithanimprovedea...
Breaking Medicine News(10 mins):Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3
...v. 19 Care Improvement Plus today announced that ...del Partner Award" from the Atlanta Metropolitan P...mprovement Plus for developing a series of health ... University of Georgia Cooperative Extension Serv...
...K, Nov. 19 DECEMBER 2008 articles include: , ...Twilight star Cam Gigandet has a number of goals ...eat career and general happiness. He shares his i...s O.C. co-stars, Gigandet is candid about how he p...
...approach could aid research, treatment, experts sa...-- U.S. researchers say they,ve developed a new lo...ival of cancer-killing cells within the body. , Mo...tanford University School of Medicine reports. How...
..., Nov. 19 Today talk show host, Larry King,turns ...King Cardiac,Foundation, COPE Health Solutions and...e second annual King of Hearts gala in Los Angeles...ed a heart,attack, one that led to quintuple-bypas...
... Va., Nov. 19 Recognizing November 20th as the 33...an Cancer Society, the National Community Pharmaci...resolution asking its pharmacist members to consid...od health and the use of tobacco products is an un...
... Nov. 19 In nearly one third of all people who,su...jury is not readily,evident to doctors. Atrial fi...ieved to be a significant factor in many of these ...y.org/cgi/content/abstract/71/21/1696 ) that a new...
Other Medicine News:Health News:Care Improvement Plus Recognized with Metropolitan Partnership in Aging Award 2Health News:Highlights from the December 2008 Issue of Men's Health: On Newsstands November 18th, 2008 2Health News:Highlights from the December 2008 Issue of Men's Health: On Newsstands November 18th, 2008 3Health News:Highlights from the December 2008 Issue of Men's Health: On Newsstands November 18th, 2008 4Health News:Technique Tracks Cancer-Killing Cells 2Health News:The King of Hearts Helps Others Follow a Healthy Road 2Health News:The King of Hearts Helps Others Follow a Healthy Road 3Health News:The King of Hearts Helps Others Follow a Healthy Road 4Health News:NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products 2Health News:Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Unclear 2Health News:Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Unclear 3
(Date:11/23/2009)...,Nov.23/PRNewswire/--LightSciencesOncology,Inc.(LS...oftheBoard,Elekta,toanewlycreatedseatonitsboardofd...medical-productcompanies,includingElekta,tomarketl...gsadditionalstrengthinbusinessdevelopmenttotheboar...ighisaworldleaderincancer-therapybusinessdevelopme...
(Date:11/23/2009)....,Nov.23/PRNewswire-FirstCall/-- CumberlandPharmac...p-lineresultsfromastudyevaluatingthesafetyandeffic...inhospitalizedburnpatients. ,, Statisticalsigni...everinburnpatientsoverthefirst24hoursoftreatment.T...rddegreeburnscoveringmorethan10percenttotalbodysur...
(Date:11/23/2009)...s,Nov.23/PRNewswire-FirstCall/--WoundManagementTec...ingproviderofspecialtymedicalproducts,announcedtha...comprehensivemanagementbusinessupdatetoillustratet...2009salesincreased33.5%to$102,926vs.Q32008salesof$...asedto$3,327,892vs.Q32008shareholderequityof$(321,...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 1Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 2WarrantyElephant Launches 26quot 3BMediElephant 26quot 3B a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis Founder o 59503 1WarrantyElephant Launches 26quot 3BMediElephant 26quot 3B a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis Founder o 59503 2You Me and Tea is Pleased to Announce the Website Debut of youmeandtea com 59498 1You Me and Tea is Pleased to Announce the Website Debut of youmeandtea com 59498 2
..., Calif., June 2 ,Bayer HealthCare Pharmaceuticals...XX ) today announced the presentation of new clini...elopment program for Nexavar(R),(sorafenib) tablet...gastric and ovarian cancers. Nexavar is currently ...nt of patients with unresectable liver cancer and,...
...edarex, Inc.,(Nasdaq: MEDX ) today announced prel...1106 (ONO-4538: development code of Ono Pharmaceut...Data presented from patients with,recurrent or tre... safety,tolerability and pharmacokinetic profile o...vidence of anti-tumor activity was observed,includ...
Other Medicine Technology:New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 2New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 4New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 5New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 2Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 3Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 4
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: